Thunen Shelley B
SEC-identified person · CIK 1297491 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Priveterra Acquisition Corp. PMGM | Director | filed 2023–2026 |
| Lenz Therapeutics, Inc. LENZ | Director | filed 2024–2026 |
| Rxsight, Inc. RXST | See remarks | filed 2021–2025 |
| Venus Concept Inc. VERO | Director | filed 2017–2018 |
| Endologix INC /DE/ ELGX | Chief Financial Officer | filed 2013–2015 |
| Intralase Corp ILSE | EVP & CFO | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.